Drug Patent Expirations for the Week of June 26, 2022

PRADAXA (dabigatran etexilate mesylate) Boehringer ingelheim Patent: 6,087,380 Expiration: Jun 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent …


New patent expiration for Genzyme Corp drug CAPRELSA

Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Genzyme Corp drug CAPRELSA appeared first…


Biotechblog